Regeneron Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$635.45(as of Jun 5, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regeneron Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$635.45
Ticker SymbolREGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15,343
CountyUSA
Market Cap$66,620.0M
EBIDTA4,382.8M
10-Day Moving Average622.43
P/E Ratio15.47
20-Day Moving Average652.52
Forward P/E Ratio14.16
50-Day Moving Average706.29
Earnings per Share40.99
200-Day Moving Average694.15
Profit Margin20.17%
RSI40.86
Shares Outstanding103.0M
ATR19.01
52-Week High818.90
Volume975,800
52-Week Low491.73
Book Value31,423.6M
P/B Ratio2.18
Upper Keltner695.30
P/S Ratio4.59
Lower Keltner609.74
Debt-to-Equity Ratio695.30
Next Earnings Date07/30/2026
Cash Surplus-2,145.1M
Next Ex-Dividend DateUnknown
Looking for a prescription for success? Then this could be the stock for you. Regeneron is at the forefront of biotechnology that develops and commercializes life-transforming medicines. They are best known for their blockbuster drug Eylea, which is used to treat age-related macular degeneration—a leading cause of blindness in the elderly.
Regeneron Pharmaceuticals Inc In Our Stock Scanner
As of Jun 08, 2026
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.